Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Caladrius Biosciences Inc | CLBS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.09 | 3.67% | 2.54 | 2.57 | 2.54 | 2.57 | 2.45 | 10:51:44 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.48 | 2.64 | 0.16 | 6.06% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10 | 929 | $ 2.57 | $ 2,384 | 14,772 | 2.16 - 6.83 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:57:09 | 2 | $ 2.56 | USD |
Caladrius Biosciences Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 26.73M | 10.40M | $ -16.17M | -1.66 | - | 2.33M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Caladrius Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLBS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.45 | 2.75 | 2.26 | 2.5987 | 18k | 0.09 | 3.67% |
| 1 Month | 2.34 | 2.75 | 2.2 | 2.5045 | 12k | 0.2 | 8.55% |
| 3 Months | 2.23 | 3.2 | 2.16 | 2.6560 | 32k | 0.31 | 13.90% |
| 6 Months | 3.83 | 3.8414 | 2.16 | 2.8361 | 34k | -1.29 | -33.68% |
| 1 Year | 6.19 | 6.83 | 2.16 | 3.7478 | 34k | -3.65 | -58.97% |
| 3 Years | 4.82 | 11.65 | 2.16 | 5.6462 | 70k | -2.28 | -47.30% |
| 5 Years | 23 | 23.5 | 2.16 | 9.3471 | 121k | -20.46 | -88.96% |
Caladrius Biosciences Description
| Caladrius Biosciences Inc is a therapeutics development biopharmaceutical company. It is engaged in the development of products that have the potential to restore the health of people with chronic illnesses. The company' product candidates include three developmental treatments for cardiovascular diseases; CLBS12 for the treatment of critical limb ischemia (CLI); CLBS14-CMD for the treatment of coronary microvascular dysfunction (CMD); CLBS14-NORDA for no-option refractory disabling angina (NORDA); and one autoimmune product candidate, CLBS03, an ex vivo expanded polyclonal T regulatory cell therapy for the treatment of Type 1 diabetes. |
